Shigeru Yoshida Selected Research

Tuberculin (PPD)

7/2022	Machine learning prediction models for postpartum depression: A multicenter study in Japan.
1/2022	Pre-pregnancy sleep duration and postpartum depression: a multicenter study in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeru Yoshida Research Topics

Disease

8	Hyperalgesia 01/2023 - 11/2007
8	Type 2 Diabetes Mellitus (MODY) 11/2016 - 09/2010
8	Stroke (Strokes) 05/2008 - 08/2002
5	Visceral Pain 01/2023 - 01/2016
5	Infarction (Infarctions) 03/2017 - 08/2002
5	Ischemic Stroke 03/2009 - 08/2002
4	Pain (Aches) 01/2023 - 01/2016
4	Neoplasms (Cancer) 01/2023 - 05/2002
4	Brain Ischemia (Cerebral Ischemia) 03/2017 - 05/2006
3	Glioma (Gliomas) 05/2009 - 04/2005
3	Brain Edema (Cerebral Edema) 03/2009 - 03/2007
2	Inflammation (Inflammations) 01/2023 - 11/2007
2	Wounds and Injuries (Trauma) 01/2023 - 04/2012
2	Pancreatitis 01/2023 - 01/2016
2	Neuralgia (Stump Neuralgia) 01/2023 - 01/2018
2	Cystitis 01/2023 - 01/2016
2	Intractable Pain 12/2022 - 01/2018
2	Postpartum Depression (Post-Natal Depression) 07/2022 - 01/2022
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 12/2017 - 07/2015
2	Overweight 12/2017 - 07/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 10/2015
2	Insulin Resistance 09/2013 - 06/2006
2	Infections 12/2012 - 01/2008
2	Carcinogenesis 12/2012 - 10/2002
2	Neuroblastoma 05/2009 - 09/2007
2	Alzheimer Disease (Alzheimer's Disease) 03/2008 - 07/2005
2	Cognitive Dysfunction 03/2008 - 01/2006
2	Thrombotic Stroke 10/2007 - 08/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2007 - 08/2002
2	Reperfusion Injury 05/2006 - 11/2004
1	Catalepsy 12/2022
1	Liver Diseases (Liver Disease) 12/2022
1	Pregnancy Complications 12/2022
1	Hemolysis 12/2022
1	Pre-Eclampsia (Preeclampsia) 12/2022
1	Hemorrhage 11/2021
1	Headache (Headaches) 11/2020
1	Vomiting 11/2020
1	Nausea 11/2020
1	Dizziness (Lightheadedness) 11/2020
1	Sleepiness 11/2020

Drug/Important Bio-Agent (IBA)

4	sodium sulfideIBA 01/2023 - 02/2014
4	T-Type Calcium Channels (T-Type Calcium Channel)IBA 12/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 03/2009 - 03/2007
3	EnzymesIBA 01/2023 - 11/2007
3	GasotransmittersIBA 01/2023 - 11/2007
3	Protein Isoforms (Isoforms)IBA 12/2022 - 02/2013
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 11/2007
3	SodiumIBA 03/2017 - 09/2007
3	sodium bisulfide (NaHS)IBA 01/2016 - 11/2007
3	LigandsIBA 12/2012 - 06/2006
3	Dizocilpine Maleate (Dizocilpine)IBA 10/2007 - 06/2007
2	CeruletideIBA 01/2023 - 01/2016
2	Cysteine (L-Cysteine)FDA Link 01/2023 - 11/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2016
2	Tuberculin (PPD)IBA 07/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2005
2	Arginine (L-Arginine)FDA Link 12/2017 - 07/2015
2	Sodium-Glucose Transport ProteinsIBA 03/2017 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 10/2010
2	NNC 55-0396IBA 02/2014 - 02/2013
2	Insulin (Novolin)FDA Link 09/2013 - 11/2010
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2013 - 10/2010
2	Ethosuximide (Zarontin)FDA LinkGeneric 02/2013 - 11/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2010 - 09/2010
2	XenonIBA 01/2010 - 08/2002
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 12/2007 - 05/2006
2	N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamideIBA 12/2007 - 05/2006
2	Neuroprotective AgentsIBA 08/2007 - 06/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2007 - 05/2006
2	PPAR gammaIBA 06/2006 - 03/2003
2	SaltsIBA 04/2005 - 11/2004
2	SEA 0400IBA 11/2004 - 11/2004
2	TTC 909IBA 04/2003 - 08/2002
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2003 - 08/2002
2	LipidsIBA 04/2003 - 08/2002
2	TEI 9090 (clinprost)IBA 04/2003 - 08/2002
2	ValeratesIBA 04/2003 - 08/2002
2	9-O-methanoprostaglandin IIBA 04/2003 - 08/2002
2	ThromboxanesIBA 04/2003 - 08/2002
2	ozagrelIBA 04/2003 - 08/2002
2	Ligases (Synthetase)IBA 04/2003 - 08/2002
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	SulfurIBA 01/2023
1	GermaniumIBA 01/2023
1	LyasesIBA 01/2023
1	3-(trihydroxygermyl)propanoic acidIBA 01/2023
1	CystathionineIBA 01/2023
1	Pimozide (Orap)FDA Link 12/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022
1	Transaminases (Aminotransferases)IBA 12/2022
1	Calcium Channels (Calcium Channel)IBA 07/2019
1	2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA 07/2019

Therapy/Procedure

3	Therapeutics 09/2013 - 06/2007
2	Oral Administration 11/2020 - 02/2013
2	Ligation 01/2018 - 01/2018
2	Microspheres (Microsphere) 04/2003 - 08/2002
1	Blood Transfusion (Blood Transfusions) 11/2021
1	Hysterectomy 11/2021